Acclarent, Inc. began as a privately held, venture-backed company, and is now a subsidiary of Integra LifeSciences. Based in Irvine, Orange County,

California California () is a U.S. state, state in the Western United States that lies on the West Coast of the United States, Pacific Coast. It borders Oregon to the north, Nevada and Arizona to the east, and shares Mexico–United States border, an ...

. it develops technology for ENT (Ear, Nose and Throat) related illnesses.

History

Founded in 2004. Acclarent has over 300 employees and operates in more than 45 countries. Acclarent’s corporate headquarters are located in the

Silicon Valley Silicon Valley is a region in Northern California that is a global center for high technology and innovation. Located in the southern part of the San Francisco Bay Area, it corresponds roughly to the geographical area of the Santa Clara Valley ...

Menlo Park, California Menlo Park ( ) is a city at the eastern edge of San Mateo County, California, San Mateo County in the San Francisco Bay Area of California, United States. It is bordered by San Francisco Bay on the north and east; East Palo Alto, California, Eas ...

. Since inception, the firm has reported more than $103.5M in funding from its venture partners,

New Enterprise Associates New Enterprise Associates (NEA) is an American-based venture capital firm. NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With over $25 billion in committed capital, NEA is one of t ...

(NEA), Versant Ventures, Delphi Ventures, Meritech Capital Partners, and Johnson & Johnson Development Corporation. Acclarent was founded by Joshua Makower who currently serves as Acclarent’s Chairman of the Board. William M. Facteau was the company's President and Chief Operating Officer from November 2004 until March 2012. The company's president is currently Jeff Hopkins. In May 2005, Acclarent received FDA approval for its Relieva Balloon Sinuplasty technology. The company’s portfolio has more than 40 FDA-approved devices including the Relieva Balloon Sinuplasty systems, comprising the Relieva Ultirra sinus balloon catheters, the Relieva Luma sinus illumination guidewires, the Relieva Vortex which provides deep intra-sinus fluid delivery and strong shear flows to empty sinus contents, and the Cyclops articulating endoscope. In January 2010, Ethicon Inc., a

Johnson & Johnson Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a c ...

company, completed the acquisition of Acclarent. In September 2017, the firm received FDA clearance for the Aera balloon, the first ever device to treat chronic eustachian tube dysfunction. In December 2023, Integra LifeSciences announced they were acquiring Acclarent for $275m. The transaction was completed on April 1, 2024.

References

External links

*
Official USA patient website

Official UK patient website
{{Authority control Companies based in Menlo Park, California American companies established in 2004 2024 mergers and acquisitions